Sanofi Successfully Prices €1.5 Billion Offering Under Euro Medium Term Note Program
March 6, 2025 | Thursday | News
Sanofi has successfully priced its €1.5 billion offering of notes across two tranches under its Euro Medium Term Note (EMTN) Program, reinforcing its financial strategy and long-term growth plans.
The offering includes:
- €850 million floating rate notes, due March 2027, bearing interest at 3-month Euribor + 0.300%.
- €650 million fixed rate notes, due March 2031, bearing interest at an annual rate of 2.750%.
Sanofi intends to utilize the net proceeds from the offering for general corporate purposes, supporting its ongoing operational and strategic initiatives.
The transaction was led by Deutsche Bank and J.P. Morgan as Global Coordinators, with ING, Santander CIB, and UniCredit acting as Joint Lead Managers.
